Basmisanil Completed Phase 2 Trials for Down Syndrome (DS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02024789A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)